News | September 07, 2023
Biocon Biologics completes integration of Viatris Biosimilars’ business in North America
Biocon Biologics recently acquired the global biosimilars business of its long-term partner Viatris
Biocon Biologics recently acquired the global biosimilars business of its long-term partner Viatris
These plant locations include Ramagundam, Talcher Kaniha, Korba, Vindhyachal, Dadri, Barh, Solapur, North Karanpura, and Mauda
This indigenously developed enhanced care technology is designed to continuously monitor and detect early signs of deterioration in a patient's condition
Aims to build the largest connected healthcare ecosystem in India
Weinand is the former CEO and Chairman of the Board at Bayer Pharma AG, leading Bayer’s fully integrated $20 billion healthcare business
With India supplying around 60% of the world's vaccine needs and 20-22% of generic exports, the country is dedicated to providing affordable, high-quality drugs and contribute to global accessibility
Glenmark's current portfolio consists of 184 products authorized for distribution in the U.S. marketplace
Combination creates an integrated provider of drug development and regulatory consulting services serving a complementary client base
CiplaMed 2.0 leverages advanced analytics and automation
Ryan has nearly 20 years of global legal and IP expertise in the pharmaceutical industry
Subscribe To Our Newsletter & Stay Updated
